Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Download
Flag content
0
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinoma
Oncology
Internal Medicine
Hepatology
Show More
Authors
Shinsuke Uchikawa
,
Tomokazu Kawaoka
Serami Murakami
,
Ryo Miura
,
Yuki Shirane
,
Yusuke Johira
,
Masanari Kosaka
,
Yasutoshi Fujii
,
Hatsue Fujino
,
Atsushi Ono
,
Eisuke Murakami
,
Daiki Miki
,
C. Hayes
,
Masataka Tsuge
+12 authors
,
Shiro Oka
Journal
Hepatology Research
Published
Aug 17, 2024
DOI
10.1111/hepr.14104
Show more
Save
Tip
Document
Download
Flag content
0
Tip
Save
Document
Download
Flag content
Paper
Conversation
Grants
Reviews
Post
Best
Best
Newest
Upvoted
Start the discussion.
This paper has not yet been discussed.